Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Surveillance strategies after definitive therapy of invasive bladder cancer.

Literature DB >> 20019993

Surveillance strategies after definitive therapy of invasive bladder cancer.

Abstract

Following definitive therapy for muscle invasive bladder cancer, patients remain at risk for local and distant recurrence. Additionally, recurrences can result from formation of new tumours elsewhere in the urinary tract. We review patterns of recurrence and the prognosis associated with recurrence. Optimal surveillance strategies are discussed.

Entities: Disease Species

Year: 2009 PMID： 20019993 PMCID： PMC2792448 DOI： 10.5489/cuaj.1205

Source DB: PubMed Journal: Can Urol Assoc J ISSN： 1911-6470 Impact factor: 1.862

48 in total

1. Local recurrence and survival following nerve-sparing radical cystoprostatectomy.

Authors: C B Brendler; G D Steinberg; F F Marshall; J L Mostwin; P C Walsh
Journal: J Urol Date: 1990-11 Impact factor: 7.450

2. Local recurrence after cystectomy alone for bladder carcinoma.

Authors: K M Greven; J A Spera; L J Solin; T Morgan; G E Hanks
Journal: Cancer Date: 1992-06-01 Impact factor: 6.860

3. Urethral recurrence of transitional cell carcinoma of the bladder. Predictive value of preoperative latero-montanal biopsies and urethral frozen sections during prostatocystectomy.

Authors: T Lebret; J M Hervé; P Barré; F Gaudez; P M Lugagne; M Barbagelatta; H Botto
Journal: Eur Urol Date: 1998 Impact factor: 20.096

4. Urethral recurrence in patients with orthotopic ileal neobladders.

Authors: J A Freeman; T A Tarter; D Esrig; J P Stein; D A Elmajian; S C Chen; S Groshen; G Lieskovsky; D G Skinner
Journal: J Urol Date: 1996-11 Impact factor: 7.450

5. Oncological followup after radical cystectomy for bladder cancer-is there any benefit?

Authors: Bjoern G Volkmer; Rainer Kuefer; Georg C Bartsch; Kilian Gust; Richard E Hautmann
Journal: J Urol Date: 2009-02-23 Impact factor: 7.450

6. Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors.

Authors: Paul D Sved; Pablo Gomez; Alan M Nieder; Murugesan Manoharan; Sandy S Kim; Mark S Soloway
Journal: BJU Int Date: 2004-10 Impact factor: 5.588

7. Effective bladder sparing therapy with intra-arterial cisplatin and radiotherapy for localized bladder cancer.

Authors: Libni Eapen; David Stewart; John Collins; Rebecca Peterson
Journal: J Urol Date: 2004-10 Impact factor: 7.450

8. Transitional cell carcinoma of the urethra in men following cystectomy for bladder cancer: multivariate analysis for risk factors.

Authors: K Tobisu; Y Tanaka; T Mizutani; T Kakizoe
Journal: J Urol Date: 1991-12 Impact factor: 7.450

Review 9. Bladder preservation: optimizing radiotherapy and integrated treatment strategies.

Authors: Raymond H Mak; Anthony L Zietman; Niall M Heney; Donald S Kaufman; William U Shipley
Journal: BJU Int Date: 2008-11 Impact factor: 5.588

10. Management of the urethra in patients undergoing radical cystectomy for bladder carcinoma.

Authors: J C Baron; L B Gibod; A Steg
Journal: Eur Urol Date: 1989 Impact factor: 20.096

11 in total

1. Rational or rationing? Justifying follow-up after management of kidney cancer.

Authors: D Robert Siemens
Journal: Can Urol Assoc J Date: 2010-10 Impact factor: 1.862

2. Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study.

Authors: Libni J Eapen; Edward Jones; Wassim Kassouf; Carole Lambert; Scott C Morgan; Madeleine Moussa; Robert Nam; Matthew Parliament; Laurie Russell; Fred Saad; D Robert Siemens; Luis Souhami; Ewa Szumacher; Scott Tyldesley; Yan Xu; Ingrid Zbieranowski; Rodney H Breau; Eric Belanger; Peter Black; Eric Estey; Julie Bowan; Bishwajit Bora; Michael Brundage; Peter Chung; Neil Fleshner; Andrew Evans; Glenn Bauman; Jonathan Izawa; Chris Davidson; Fadi Brimo
Journal: Can Urol Assoc J Date: 2016 Mar-Apr Impact factor: 1.862

3. SEOM clinical guidelines for the treatment of invasive bladder cancer.

Authors: Rafael Morales; Albert Font; Joan Carles; Dolores Isla
Journal: Clin Transl Oncol Date: 2011-08 Impact factor: 3.405

4. A smoking cessation program as a resource for bladder cancer patients.

Authors: Daniel Vilensky; Nathan Lawrentschuk; Karen Hersey; Neil E Fleshner
Journal: Can Urol Assoc J Date: 2011-05-01 Impact factor: 1.862

5. A case of isolated rectal recurrence of muscle invasive bladder cancer.

Authors: Shaqil N Kassam; Zared Aziz; Lick San Hung; Srikala S Sridhar
Journal: Can Urol Assoc J Date: 2013 May-Jun Impact factor: 1.862

6. SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).

Authors: A González Del Alba; M Lázaro; E Gallardo; M Doménech; Á Pinto; A González-del-Alba; J Puente; O Fernández; A Font; N Lainez; S Vázquez
Journal: Clin Transl Oncol Date: 2016-11-29 Impact factor: 3.405

7. Rare Occurrence of a Poorly Differentiated Neuroendocrine Tumor of the Bladder.

Authors: Katherine Dowd; Charles Rotenberry; Douglas Russell; Mitchell Wachtel; Werner de Riese
Journal: Case Rep Med Date: 2017-01-02

Review 8. Genetic determinants for chemo- and radiotherapy resistance in bladder cancer.

Authors: Andrea Mari; David D'Andrea; Mohammad Abufaraj; Beat Foerster; Shoji Kimura; Shahrokh F Shariat
Journal: Transl Androl Urol Date: 2017-12

9. Transitional cell carcinoma recurrence impacting intestinal diversion after radical cystectomy. Oncologic outcomes of a rare site of recurrence.

Authors: Fabio Zattoni; Iliana Bednarova; Alessandro Morlacco; Giovanni Motterle; Paolo Beltrami; Fabrizio Dal Moro; R Jeffrey Karnes
Journal: Cent European J Urol Date: 2020-12-09

10. Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine.

Authors: Yong-Tong Zhu; Shi-Yu Pang; Cheng-Yong Lei; Yang Luo; Qing-Jun Chu; Wan-Long Tan
Journal: Stem Cell Res Ther Date: 2015-11-14 Impact factor: 6.832